Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 494 entries
View as:

A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01518894 Org: User:
Start: 11/30/11 End: 03/31/12 Due: 03/31/13

RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR

Phase: N/A Priority: Normal
NCT ID: NCT02255422 Org: User:
Start: 05/05/15 End: 11/30/17 Due: 11/30/18

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Phase: N/A Priority: Normal
NCT ID: NCT06962800 Org: User:
Start: 05/22/25 End: 03/29/29 Due: 03/29/30

Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy

Phase: N/A Priority: Normal
NCT ID: NCT04089566 Org: User:
Start: 03/26/20 End: 05/30/24 Due: 05/30/25

A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Phase: N/A Priority: Normal
NCT ID: NCT03692910 Org: User:
Start: 08/23/18 End: 05/21/19 Due: 05/21/20

Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00745316 Org: User:
Start: 02/28/09 End: 01/31/10 Due: 01/31/11

Natalizumab (Tysabri) Re-Initiation of Dosing

Phase: N/A Priority: Normal
NCT ID: NCT00297232 Org: User:
Start: 03/31/06 End: 04/30/14 Due: 04/30/15

Tysabri Observational Program

Phase: N/A Priority: Normal
NCT ID: NCT00493298 Org: User:
Start: 06/29/07 End: 11/01/23 Due: 11/01/24

A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02341482 Org: User:
Start: 02/05/15 End: 03/31/15 Due: 03/31/16

Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00555724 Org: User:
Start: 01/31/08 End: 07/31/10 Due: 07/31/11

Study Of The PF-04958242 Blood Concentrations Of A Capsule Formulation Of PF-04958242 Compared To A Solution Formulation

Phase: N/A Priority: Normal
NCT ID: NCT01646840 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

An Observational Study Using Multimodal Sensors to Measure Cognitive Health in Adults and Distinguish Mild Cognitive Impairment From Normal Aging

Phase: N/A Priority: Normal
NCT ID: NCT05058950 Org: User:
Start: 09/20/21 End: 09/19/23 Due: 09/19/24

BG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT00835770 Org: User:
Start: 02/03/09 End: 11/08/19 Due: 11/08/20

An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)

Phase: N/A Priority: Normal
NCT ID: NCT01494701 Org: User:
Start: 11/30/11 End: 01/31/13 Due: 01/31/14

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Phase: N/A Priority: Normal
NCT ID: NCT02555215 Org: User:
Start: 02/22/16 End: 09/24/18 Due: 09/24/19

Pilot Tape Harvesting Study

Phase: N/A Priority: Normal
NCT ID: NCT02125695 Org: User:
Start: 05/31/14 End: 08/31/16 Due: 08/31/17

Administration of BIIB028 to Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00725933 Org: User:
Start: 06/30/08 End: 10/31/11 Due: 10/31/12

Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01453426 Org: User:
Start: 01/31/12 End: 04/30/12 Due: 04/30/13

A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06640933 Org: User:
Start: 10/16/24 End: 02/07/25 Due: 02/07/26

A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Phase: N/A Priority: Normal
NCT ID: NCT05688436 Org: User:
Start: 09/24/21 End: 01/17/31 Due: 01/17/32

Canadian Avonex PEN Productivity Study

Phase: N/A Priority: Normal
NCT ID: NCT01489748 Org: User:
Start: 03/31/12 End: 12/31/14 Due: 12/31/15

A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).

Phase: N/A Priority: Normal
NCT ID: NCT02462759 Org: User:
Start: 08/19/15 End: 09/24/18 Due: 09/24/19

Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT01597297 Org: User:
Start: 08/31/12 End: 08/31/13 Due: 08/31/14

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00057343 Org: User:
Start: 03/31/03 End: - Due: -

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03958877 Org: User:
Start: 10/18/19 End: 05/20/27 Due: 05/20/28